Female Sexual Dysfunction Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Billing Details

Captcha refresh

Continue for Payment Method

Pay with Strip
Total: $ 4850
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X